Medical Ikkou GroupLtd Management
Management criteria checks 2/4
Medical Ikkou GroupLtd's CEO is Toshihisa Minamino, appointed in Apr 1985, has a tenure of 39.75 years. directly owns 6.44% of the company’s shares, worth ¥496.68M. The average tenure of the management team and the board of directors is 2 years and 4.7 years respectively.
Key information
Toshihisa Minamino
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 39.8yrs |
| CEO ownership | 6.4% |
| Management average tenure | 2yrs |
| Board average tenure | 4.7yrs |
Recent management updates
Recent updates
Shareholders Will Be Pleased With The Quality of Medical Ikkou GroupLtd's (TSE:3353) Earnings
Oct 14
Does Medical Ikkou GroupLtd (TSE:3353) Have A Healthy Balance Sheet?
Aug 08Statutory Profit Doesn't Reflect How Good Medical Ikkou GroupLtd's (TSE:3353) Earnings Are
Apr 13We Think Medical Ikkou GroupLtd (TSE:3353) Can Stay On Top Of Its Debt
Apr 05Read This Before Buying Medical Ikkou Group Co.,Ltd. (TYO:3353) For Its Dividend
May 09How Well Is Medical Ikkou GroupLtd (TYO:3353) Allocating Its Capital?
Mar 21Here's Why Medical Ikkou GroupLtd (TYO:3353) Has A Meaningful Debt Burden
Mar 06Medical Ikkou Group Co.,Ltd. (TYO:3353) Will Pay A JP¥40.00 Dividend In Four Days
Feb 19What Medical Ikkou Group Co.,Ltd.'s (TYO:3353) ROE Can Tell Us
Feb 09Key Things To Consider Before Buying Medical Ikkou Group Co.,Ltd. (TYO:3353) For Its Dividend
Jan 25Can You Imagine How Medical Ikkou GroupLtd's (TYO:3353) Shareholders Feel About The 43% Share Price Increase?
Jan 10
What Type Of Shareholders Make Up Medical Ikkou Group Co.,Ltd.'s (TYO:3353) Share Registry?
Dec 27Returns On Capital Tell Us A Lot About Medical Ikkou GroupLtd (TYO:3353)
Dec 13Here's Why We Don't Think Medical Ikkou GroupLtd's (TYO:3353) Statutory Earnings Reflect Its Underlying Earnings Potential
Nov 30CEO
Toshihisa Minamino (68 yo)
39.8yrs
Tenure
Mr. Toshihisa Minamino has been the President of Medical Ikkou Group Co.,Ltd. (formerly known as Medical Ikkou Co., Ltd.) since April 1985 and is its Group Chief Executive Officer since September 2019. .M...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 39.8yrs | no data | 6.44% ¥ 496.7m | |
| Director of Accounting | no data | no data | 0.0027% ¥ 205.0k | |
| Senior Executive Officer | 2yrs | no data | no data | |
| Senior MD of General Management & Representative Director | no data | no data | 0.27% ¥ 20.9m | |
| Senior Executive Officer | 2yrs | no data | no data | |
| Senior Executive Officer & GM of Group Audit & Management Office | no data | no data | no data | |
| Senior Executive Officer and Planning & Management Department Manager | 4yrs | no data | no data | |
| Senior Executive Officer | 2yrs | no data | no data |
2.0yrs
Average Tenure
64yo
Average Age
Experienced Management: 3353's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 39.8yrs | no data | 6.44% ¥ 496.7m | |
| Director of Accounting | no data | no data | 0.0027% ¥ 205.0k | |
| Senior MD of General Management & Representative Director | 10.7yrs | no data | 0.27% ¥ 20.9m | |
| External Auditor | 9.7yrs | no data | 0.0053% ¥ 410.1k | |
| External Auditor | 12.7yrs | no data | 0.072% ¥ 5.5m | |
| Independent Outside Director | 1.7yrs | no data | no data | |
| Full-Time Auditor | 4.7yrs | no data | 0.032% ¥ 2.5m | |
| Outside Auditor | 4.7yrs | no data | no data | |
| Independent Outside Director | 3.7yrs | no data | no data | |
| Outside Independent Director | less than a year | no data | no data |
4.7yrs
Average Tenure
69yo
Average Age
Experienced Board: 3353's board of directors are considered experienced (4.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 16:06 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/08/31 |
| Annual Earnings | 2024/02/29 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medical Ikkou Group Co.,Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Takumi Yamagishi | Mizuho Securities Co., Ltd. |